ROOKER DAVID PHILIP

No ORCID on file · 49 papers in corpus · active 2003-2008
2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2008
Non-peptide GnRH antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2006
Compounds of non-peptide GnRH (LHRH) antagonists formulated as medicinal compositions for treating conditions wherein GnRH in the pathophysiology

Disclosed is a compound which is a derivative of general formula 1, wherein the substituents are as defined in the specification. The composition is useful in the treatment of hormone dependent cancer, endometriosis, benign prostate hyperpl…

2005
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2005
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2005
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…

2005
Non-peptide gnrh antagonists

Compounds according to general formula 1, wherein A-Aare selected from Aand Awhere Ais either -CR- or -N- and Ais -NR-, -O- or -S-; Ais either a covalent bond or A, provided that when Ais a covalent bond one of A-Amust be Aand the other two…